Synthesis of oxiracetam derivatives and their nootropic activities
SONG Yan-ling;SUN Qiao;LI Bai-na;LIU Xiao-juan;Department of Pharmaceutical Engineering;Shenyang University of Chemical Technology;

..............page:1195-1198

Synthesis of glycyrrhetinic acid-matrine complexes and their antitumor activities
ZHANG-Na;CUI Xiao-yan;ZHAO Xiu-mei;LI Dong-dong;DAI Lin-lin;TAO Zun-wei;Tianjin Institute of Medical Pharmaceutical Sciences;School of Graduate;Tianjin Medical University;

..............page:1199-1202

Effect of Chir99021 combined with PD0325901 on differential expression of mi RNAs in embryonic stem cells of mouse
MA Yi-xiang;Shanghai Second People’s Hospital;

..............page:1203-1208

Absorption mechanism of L-valyl-α-hederin in leptin-treated Caco-2 cells
SUN Yong-bing;FU Guo-qiang;XIE Jun-xia;ZHANG Peng;Jiangxi University of Traditional Chinese Medicine;Hebei College of Chemical and Pharmacy;College of Pharmacy;Shenyang Pharmaceutical University;

..............page:1209-1213

Effects of rivaroxaban and its antagonists on hemorrhage model in rats
SUN Shuang-yong;LI Ya-li;ZHENG Hai-juan;WANG Wei-ting;ZHAO Zhuan-you;Tianjin Center for New Drug Safety Assessment and Research;

..............page:1214-1218

Effects of PEG-rh GH on organ function of hypophysectomized rats
CHENG Pan-gui;ZHANG Zhi-xin;PAN Lin;LIN Ying-ke;YANG Ye;ZHAO Qiu-ling;LI Hong;HE Chun;China-Japan Friendship Hospital;Institute of Clinical Medical;China-Japan Friendship Hospital;Hepingli Hospital of Beijing City;

..............page:1219-1223

Effect of oxytocin on glucose and lipid metabolism of 3T3-L1 adipocytes
ZHU Tian-yi;QIAN Wei-yun;TANG Bing-qian;HU Hao;YU Shu-qin;SUN Wen-jun;YUAN Guo-yue;Jiangsu Province Hospital;

..............page:1224-1226

Preparation optimization of adefovir-β-cyclodextrin inclusion complex by central composite design and response surface methodology
WANG Bo;LI Hong-qi;LIAN Xiao-yan;REN Xiao-wen;XU Wei-ren;The Pharmaceutics Engineering Research Center;Tianjin Institute of Pharmaceutical Research;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics;Tianjin Institute of Pharmaceutical Research;Tianjin Key Laboratary of Molecular Design and Drug Discovery;Tianjin Institute of Pharmaceutical Research;

..............page:1227-1230

Prescription of Jinqiaomai Total Favonoids Soft Capsule
DONG Yan;LI Wei;SHENG Yi-ling;ZHANG Xiang-rong;School of Traditional Chinese Materia Medica;Shenyang Pharmaceutical University;School of Life Science and Biopharmaceutics;Shenyang Pharmaceutical University;

..............page:1231-1233

Optimization of decolorization technology of Sophora alopecuroides polysaccharide with H₂O₂ by orthogonal test
WANG Wen-tong;ZHANG Yan;TAO Zun-wei;Tianjin Institute of Medical Sciences;

..............page:1234-1237

Quality analysis of Compound Amino Acid Injection(l8AA) from national evaluative sampling
LIU Yan;HAN Xiao-jie;HUANG Zhe-su;Tianjin Institute of Drug Control;

..............page:1238-1241

Determination of related substances in Trimetazidine Dihydrochloride Modified Release Tablets by RP-HPLC
LIU Xiao-lan;WANG Hong-mei;ZHANG Yi-hua;Sichuan Province Transportation Department Highway Bureau Hospital;Hebei Institute for Drug Control;

..............page:1242-1244

Clinical study on trimetazidine in treatment of coronary heart disease complicated with cardiac insufficiency
ZHOU Li-ping;ZHU Bin;ZHENG Yi;The Second People’s Hospital of Panzhihua City;Department of Cardiology;West China Hospital;Sichuan University;

..............page:1245-1248

Clinical efficacy of simvastatin with different doses combined with fenofibrate in treatment of type 2 diabetes complicated with hyperlipidemia
WANG Xiu-mei;GU Xue-mei;Department of Pharmacy;The Fifth Center Hospital Tianjin;Department of Endocrinology;The First Affiliated Hospital of Wenzhou Medical University;

..............page:1249-1252

Clinical observation of TC chemotherapy combined with radiotherapy in treatment of high-risk endometrial cancer after surgery
LU Ying-hua;WU Yi-bo;Department of Obstetrics and Gynecology;The Fourth People’s Hospital of Wuxi City;

..............page:1253-1256

Multi-center clinical study of Compound Wuzhigan Capsule in treatment of acute gastroenteritis
SUN Hong;HU Hai-tang;CAO Hui;CHEN Xiao-mei;XU Rui;HUANG Wen-hua;HU Ya-jing;HUANG Xiao-min;Preclinical & Clinical Center;Livzon Pharmaceutical Group Inc.;National Engineering Research Center for Modernization of TCM;Limin Pharmaceutical Factory;Livzon Pharmaceutical Group;The First Hospital Affiliated to Zhejiang University of TCM;

..............page:1257-1261

Clinical study on sequential therapy of alprostadil in treatment of diabetic nephropathy
SUN Yong-yan;YANG Ye-hong;Department of Endocrinology;The Second Hospital of Chaoyang City;Department of Endocrinology;Huashan Hospital Affiliated to Fudan University;

..............page:1262-1265

Clinical observation of leflunomide combined with irbesartan in treatment of lupus nephritis
GUO Yu-qin;ZHAO Wei-hong;Department of Internal Medicine;People’s Hospital of Jinhu County;Department of Nephrology;The First Affiliated Hospital of Nanjing Medical University;

..............page:1266-1269

Clinical observation of docetaxel combined with cisplatin in treatment of advanced esophageal cancer with synchronous radiotherapy
WANG Wei-Hua;CHEN Qian;JIANG Dao-wen;Central Hospital of Minhang District in Shanghai;

..............page:1270-1274

Clinical observation of Troxerutin Cerebroprotein Hydrolysate Injection combined with Aspirin Enteric-coated Tablets in treatment of moyamoya disease
LI Tao;MUYITI Abulimiti;LU Tong-de;The Second Affiliated Hospital of Xinjiang Medical University;Department of Surgery;Rizhao Maternal and Child Health Hospital;

..............page:1275-1278

Clinical observation of Qingfei Xiaoyan Pills combined with moxifloxacin in treatment of community acquired pneumonia
ZHAO Xiao-qin;FAN Yao-dong;The Second Hospital of Tianjin;

..............page:1279-1282

Clinical observation of peginterferon α-2a combined with adefovir dipivoxil in treatment of HBe Ag negative chronic hepatitis B
ZHANG Zhao-qin;Department of Infection;Shuyang County Central Hospital;

..............page:1283-1286

Clinical observation of Argatroban Injection in treatment of acute progressive cerebral infarction
ZHU Run-xiu;YUAN Jun;SA Ru-la;Inner Mongolia People’s Hospital;

..............page:1287-1290

Analysis on utilization of lipid-modulating agents in 34 hospitals in Wuhan City from 2011 to 2013
LEI Yong-fang;LIU Jian-fang;LUO Hao;LIU Dong;Department of Pharmacy;Tongji Hospital;Tongji Medical College of Huazhong University of Science and Technology;College of Pharmacy;Hubei University of Science and Technology;

..............page:1291-1296

Analysis on usage of Omeprazole Sodium for injection in the First Affiliated Hospital of Dalian Medical University in June 2013
CHEN Yan-wei;HE Jun;LIANG Hui;WANG Li-yan;SONG Yi;WANG Chun-fu;Department of Pharmacy;The First Affiliated Hospital of Dalian Medical University;College of Pharmacy;Dalian Medical University;

..............page:1297-1302

Cross-sectional survey on utilization of antibiotics among 1259 inpatients in Tianjin Medical University Cancer Institute and Hospital
CHEN Zheng;HAN Jian-geng;WANG Chen;Key Laboratory of Cancer Prevention and Therapy;National Clinical Research Center for Cancer;Department of Pharmacy;Tianjin Medical University Cancer Institute and Hospital;

..............page:1303-1307

Document analysis and precautions on anaphylactic shock induced by Compound Glycyrrhizin Injection
LI Hong-xia;ZHANG Jin;LIU Dong;LIU Zi-yun;ZHANG Xiao-yu;JIANG Feng-li;WU Yi-ping;Department of Pharmacy;Baoji Central Hospital;Department of Clinical Pharmacy;Baoji Central Hospital;

..............page:1308-1310

Requirements by FDA for research on abuse deterrence of opioids
WANG Yu-zhu;XIAO Hui-lai;Center for Drug Evaluation;China Food and Drug Administration;

..............page:1311-1317

Research progress on small molecule drugs for treatment of psoriasis
SUN Yue;SHI Yu;WEI Bo;XIA Chao;WEI Hui-qiang;LI Yi-liang;SUN Tie-min;Shenyang Pharmaceutical University;Tianjin Key Laboratory of Molecular Design and Drug Discovery;Tianjin Institute of Pharmaceutical Research;Tianjin University;

..............page:1318-1325

Research progress on pharmacological activities of chelidonine
ZOU Xiang;WANG Yu-meng;WANG Jia-qi;LONG Li-li;WANG Chao;LIU Ying;SHENG Jie-jing;QU Zhong-yuan;Post Doctoral Research Center;Institute of Materia Medica;Harbin University of Commarce;Engineering Research Center of Natural Antineoplastic Drugs;Ministry of Education;Harbin University of Commarce;Qiqihar Fulaerji District Hospital of Traditional Chinese Medicine;College of Pharmacy;Harbin University of Commerce;

..............page:1326-1330